MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Parkinson’s Progression Marker Initiative (PPMI) Online identifies people with features of prodromal Parkinson’s Disease through online questionnaires

    E. Brown, L. Chahine, D. Alonso, C. Coffey, R. Dobkin, T. Foroud, M. Korell, A. Lorenzo, C. Marras, W. Poewe, T. Sherer, A. Siderowf, T. Simuni, E. Tolosa, J. Valverde Twiggs, D. Weintraub, S. Chowdhury, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To implement staged screening to identify people with features of prodromal Parkinson’s disease (PD). Background: The subtle motor and non-motor symptoms that occur prior…
  • 2022 International Congress

    The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson’s: a theory-informed qualitative study.

    J. Das, G. Barry, R. Walker, R. Vitorio, R. Morris, S. Stuart (Newcastle upon Tyne, United Kingdom)

    Objective: To explore experiences of people with Parkinson’s (PwP) in using technology as part of a home-based visuo-cognitive training programme compared to traditional approaches to…
  • 2022 International Congress

    Polymorphisms in Prosaposin gene are associated with familial and early-onset Parkinson’s disease: A case-control association study and meta-analysis

    YT. Chu, MC. Kuo, YA. Su, RM. Wu (Taipei, Taiwan)

    Objective: To investigate the role of the PSAP gene in PD patients in Taiwan, including familial PD and early-onset Parkinson’s disease. Background: Mutations in the…
  • 2022 International Congress

    Status Update of EPSILON: a Phase III, Randomised, Placebo-Controlled Study of Opicapone in Early Parkinson’s Disease

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, J-F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: This study aims to explore the potential of once-daily opicapone (OPC) 50 mg to enhance the clinical benefit of levodopa (L-dopa)/dopa decarboxylase inhibitor (DDCi)…
  • 2022 International Congress

    Neuroimaging correlates of cognitive deficits in Wilson’s disease

    S. Shribman, M. Burrows, R. Convery, M. Bocchetta, C. Sudre, J. Acosta-Cabronero, D. Thomas, G. Gillett, E. Tsochatzis, O. Bandmann, J. Rohrer, T. Warner (London, United Kingdom)

    Objective: To determine the anatomical basis for cognitive deficits in WD. Background: Cognitive impairment is common in neurological presentations of Wilson’s disease (WD).1 Various cognitive domains…
  • 2022 International Congress

    Mania induced by STN-DBS is related to the stimulation of the ventromedial subthalamic nucleus in Parkinson’s disease: a prospective study

    SP. Prange, ZL. Lin, MN. Nourredine, TD. Danaila, CL. Laurencin, OLB. Lagha-Boukbiza, MA. Anheim, HK. Klinger, NL. Longato, CP. Phillipps, JV. Voirin, GP. Polo, ES. Simon, PM. Mertens, ASR. Rolland, DD. Devos, EM. Metereau, CT. Tranchant, ST. Thobois (Bron, France)

    Objective: To investigate the incidence, risk and etiological factors, clinical management and consequences of mania following subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease…
  • 2022 International Congress

    Quantitative susceptibility mapping of basal ganglia and related structures: correlation with disease severity in Progressive Supranuclear Palsy

    S. Krishnan, S. George, S. Raghavan, B. Thomas, J. Thulaseedharan, D. Puthenveedu, A. Kishore (Thiruvananthapuram, India)

    Objective: We examined whether magnetic susceptibility estimates from deep gray matter structures in patients with Progressive Supranuclear Palsy (PSP) correlated with clinical measures of disease…
  • 2022 International Congress

    Computerized assessment of handwriting in Parkinson’s disease and its relation to motor symptoms

    L. Diaz-Feliz, P. Sanz-Cartagena, M. Faundez-Zanuy, JM. Arbelo, P. García-Ruiz (Madrid, Spain)

    Objective: Computerized assessment of dysgraphia in PD de novo patients and correlation with UPDRS III. Background: Dysgraphia is a well-known motor symptom of PD, but…
  • 2022 International Congress

    Impact of GBA Mutations in the Outcomes of Deep Brain Stimulation in Parkinson’s

    M. Roque, R. Barbosa, P. Pita Lobo, A. Valadas, B. Cattoni, H. Carvalho, M. Rosa, J. Ferreira, M. Coelho, L. Guedes (Lisbon, Portugal)

    Objective: Our study aims to investigate the influence of GBA gene mutations in the outcomes of DBS in PD through the assessment of motor and…
  • 2022 International Congress

    Fever and syndrome of inappropriate antidiuretic hormone secretion induced by duloxetine intake in patient with multiple system atrophy

    J. Shi, L. Liu, J. Lin, M. Zhang, H. Liu, L. Xie (dalian, China)

    Objective: The aim of this study was to report fever and syndrome of inappropriate antidiuretic hormone secretion induced by duloxetine intake in patient with multiple system atrophy. Background:…
  • « Previous Page
  • 1
  • …
  • 139
  • 140
  • 141
  • 142
  • 143
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley